Excess visceral fat accumulation is a risk factor for postoperative systemic inflammatory response syndrome in patients with esophageal cancer

BackgroundAlthough visceral fat accumulation influences various body systems, its significance as a preoperative risk factor is unknown. This study analyzed the relationship between visceral fat accumulation and postoperative morbidity.MethodsThe study group consisted of 64 male patients with body mass index (BMI) of 18.5 or more who underwent esophagectomy for esophageal cancer. Clinicopathological, surgical, and postoperative data were collected from medical records. Visceral fat area (VFA) was calculated at the navel level of preoperative CT scan by FatScan ver. 3.0.ResultsBased on visceral fat area, patients were divided into high-VFA group (VFA ≥ 100 cm2, n = 30) and low-VFA group (VFA < 100 cm2, n = 34). Postoperative maximal CRP level was higher in the high-VFA group (23.4 ± 5.7 mg/dl) than the low-VFA group (18.5 ± 7.1 mg/dl, P = 0.004). The duration of systemic inflammatory response syndrome (SIRS) was significantly longer in high-VFA group (3.1 ± 3.4 days) than low-VFA group (1.7 ± 1.9 days, P = 0.048). There were no significant differences in postoperative complications. Differences in CRP and SIRS duration were not evident when the population was divided according to BMI. Visceral fat area (P = 0.001), blood loss (P = 0.029), and field of lymphadenectomy (P = 0.005) correlated with longer duration of SIRS postoperatively (>3 days). Multivariate analysis identified visceral fat area as the only significant determinant of longer duration of SIRS (P = 0.034; HR, 0.984).ConclusionsPatients with visceral fat area of more than 100 cm2 are at high risk for prolonged postoperative SIRS.

[1]  H. Yatsuya,et al.  Inverse association between adiponectin and C-reactive protein in substantially healthy Japanese men. , 2006, Atherosclerosis.

[2]  J. Belghiti,et al.  Surgical implications of malnutrition and immunodeficiency in patients with carcinoma of the oesophagus , 1983, The British journal of surgery.

[3]  O. Nafiu,et al.  Postoperative Complications in Obese and Nonobese Patients , 2007, World Journal of Surgery.

[4]  S. Kihara,et al.  Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages. , 2000, Blood.

[5]  H. Nagawa,et al.  Prediction of pulmonary complications after transthoracic oesophagectomy , 1994, The British journal of surgery.

[6]  R. Bone Guidelines for the Use of Innovative Therapies in Sepsis , 1993 .

[7]  T. Ishiko,et al.  Elevation of circulating interleukin 6 after surgery: factors influencing the serum level. , 1994, Cytokine.

[8]  T. Saito,et al.  Correlations between preoperative malnutrition and septic complications of esophageal cancer surgery. , 1990, Nutrition.

[9]  P. Kragsbjerg,et al.  Serum concentrations of interleukin-6, tumour necrosis factor-alpha, and C-reactive protein in patients undergoing major operations. , 1995, The European journal of surgery = Acta chirurgica.

[10]  Jacqueline Capeau,et al.  Recent advances in the relationship between obesity, inflammation, and insulin resistance. , 2006, European cytokine network.

[11]  H. Sameshima,et al.  Estimation of physiologic ability and surgical stress (E-PASS) for a surgical audit in elective digestive surgery. , 2004, Surgery.

[12]  Toshio Shimizu,et al.  Influence of Overweight on Surgical Complications for Gastric Cancer: Results From a Randomized Control Trial Comparing D2 and Extended Para-aortic D3 Lymphadenectomy (JCOG9501) , 2007, Annals of Surgical Oncology.

[13]  S. Kihara,et al.  Role of adipocytokines on the pathogenesis of atherosclerosis in visceral obesity. , 1999, Internal medicine.

[14]  S. Katayose,et al.  Decreased plasma adiponectin concentrations in women with low-grade C-reactive protein elevation. , 2003, European journal of endocrinology.

[15]  K. Walsh,et al.  Adiponectin as an anti-inflammatory factor. , 2007, Clinica chimica acta; international journal of clinical chemistry.

[16]  Eiji Oda,et al.  New criteria for 'obesity disease' in Japan. , 2002, Circulation journal : official journal of the Japanese Circulation Society.

[17]  Y. Kajiyama,et al.  Radical Lymph Node Dissection for Cancer of the Thoracic Esophagus , 1994, Annals of surgery.

[18]  W. Knaus,et al.  Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. , 1992, Chest.

[19]  K. Kobayashi,et al.  Postoperative hyperbilirubinemia after resection of thoracic esophageal cancer. , 1990, The American journal of gastroenterology.

[20]  S. Grundy,et al.  The metabolic syndrome , 2003, The Lancet.

[21]  E. Ford,et al.  Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U.S. , 2005, Diabetes care.

[22]  J. E. Carceller American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis , 1992, Critical care medicine.

[23]  D. Lau,et al.  Adipokines: molecular links between obesity and atheroslcerosis. , 2005, American journal of physiology. Heart and circulatory physiology.

[24]  Philipp E. Scherer,et al.  Visceral Fat Adipokine Secretion Is Associated With Systemic Inflammation in Obese Humans , 2007, Diabetes.

[25]  Y. Matsuzawa Metabolic syndrome--definition and diagnostic criteria in Japan. , 2005, Journal of atherosclerosis and thrombosis.

[26]  D. Kwiatkowski,et al.  Systemic cytokine response after major surgery , 1992, The British journal of surgery.